CLDN2 and colorectal cancer: Adhesion of HT-29 colorectal cancer cells display a 2.2-fold higher ability to adhere to primary Claudin-2-expressing hepatocytes when compared to Claudin-2-deficient hepatocytes (Supplementary Fig. 5c, d).